SecBot SecBot

AMIX

Autonomix Medical, Inc.
Nasdaq· Surgical & Medical Instruments & Apparatus· Inc. DE· CIK 0001617867 Healthcare & Medical Devices
$2.10 −0.32 (−13.22%)
Oct 26 4:00 PM ET · prev $2.42
Market cap
$4.9M
Nano cap
Median target
$40.80
+1843% · range $6.00–75.60
1 year
−91.2%
from $23.73 · Oct 27
30 days
−45.2%
from $3.83
52-week range
$2.10–24.15
at the low
Avg volume 20D
202.4K
Oct 2 spike 2.57M
Short interest
🔒 Subscribers only
Insider net
$0
no open-market trades · 12 mo
New fund stakes
0
Q4 2025 13F · 0 exits
Filing reports
13
analyzed by SecBot
SecBot read BEARISH 8 reports · 90 days
Balance 3 bearish · 0 bullish · 1 mixed · 4 neutral oldest → newest, height = score
Avg score ·High conf. 8/8
Strongest BEARISH Autonomix Medical's S-3 shelf registration (File No. 333-298774) became effective on September 15, 2026…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

  • InstitutionsMIXED

    Q4 2025: 2 added (0 new), 1 trimmed or exited.

  • EstimatesRISING

    Current-quarter EPS estimate −$6.195 → −$2.620 over 90 days. 1 up, 1 down in 30 days.

  • TrendDOWNTREND

    49% below its 50-day average. New closing low $2.10 on Oct 26.

Who's buying

13F· Q4 2025
0
new positions
0
exits
FundMoveSharesValue
Mariner, LLCTRIM53,143$26.5K
UBS Group AGADD127$70.00
BANK OF AMERICA CORP /DE/ADD50$28.00
UBS Group AGNEAR_EXIT79$85.00
BANK OF AMERICA CORP /DE/DOUBLED37$40.00
UBS Group AGTRIM4,461$7.0K
UBS Group AGTRIM15,941$27.9K
BANK OF AMERICA CORP /DE/ADD9$16.00

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Feb 2026
12-month targets · 2 analysts

Price is below the lowest target. Median implies +1843%.Targets as of Oct 27, 2026.

Recent actions
DateFirmActionRating
Feb 17, 2026Maxim Group
MAINTAIN
MAINTAINBuy
Apr 29, 2025Maxim Group
INITIATE
INITIATEBuy
Sep 3, 2024Ladenburg Thalmann
INITIATE
INITIATEBuy

Insider ledger

Form 4
$0
open-market buys or sells · 12 mo
DateInsiderTypeValue
Sep 3, 2026
Smith Trent N.
CFO
AWARD15,000 sh
Sep 3, 2026
Hauser Bradley
CEO and President
AWARD27,000 sh
Sep 3, 2026
Bisson Lori
Director
AWARD13,000 sh
Sep 3, 2026
KLEMP WALTER V
Director
AWARD13,000 sh

Earnings setup

Estimates
−$2.62
EPS estimate, this quarter
+58%
estimate change, 90 days
1↑ 1↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$2.62-$2.62–-$2.62+57.7%$0.00
Next Q-$1.64-$1.64–-$1.64+69.4%$0.00
Current FY-$8.60-$8.60–-$8.60+62.1%$0.00
Next FY-$12.06-$20.16–-$3.95+38.3%$0.00
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Oct 2, 2026
Earnings
Autonomix Medical Strengthens Patent Protection for Platform Technology Enabling Precision Access, Treatment Delivery and Procedural Validation
Patent expands protection for catheter-based technologies enabling transvascular access, treatment guidance, adaptive treatment delivery, and…
Sep 30, 2026
Press release
Autonomix Reports Positive FDA Feedback Supporting 510(k) Pathway to U.S. Clearance
FDA pre-submission feedback supports a Class II strategy, leveraging substantial equivalence to a previously cleared device, positioning the Company…
Sep 24, 2026
Press release
Autonomix Medical Expands Global Intellectual Property Footprint with European Patent Supporting Precision Neuromodulation Platform
European patent strengthens protection for proprietary autonomic nervous system assessment technologies, further expanding Company's international…
Aug 24, 2026
Press release
Autonomix Medical Enters into $4.9 Million Warrant Inducement Priced at a Premium to Market Under Nasdaq Rules
THE WOODLANDS, TX, Aug. 24, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company…
Aug 14, 2026
Reg SHO list
Reg SHO Threshold: AMIX exited the threshold list
AUTONOMIX MED INC COM PAR | On list since 2026-08-04

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Trading halts
Aug 6, 2026Volatility PauseResumed
Aug 4, 2026Volatility PauseResumed
Aug 4, 2026Volatility PauseResumed
Aug 4, 2026Volatility PauseResumed
Aug 4, 2026Volatility PauseResumed
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 13, 2026 SEC
Sandra C. Kalter filed an initial statement of beneficial ownership (Form 3) with Autonomix Medical, Inc., reporting…
3 — Impact 2/10
Oct 2, 2026 SEC
Autonomix Medical announced the issuance of a Canadian patent (No. 3,183,802) covering its catheter-based…
PRESS-RELEASE — Impact 3/10
Oct 2, 2026 Earnings
Autonomix Medical Strengthens Patent Protection for Platform Technology Enabling Precision Access, Treatment Delivery and Procedural Validation
Patent expands protection for catheter-based technologies enabling transvascular access, treatment g
Sep 16, 2026 SEC
Autonomix Medical appointed Sandra Cohen Kalter, former Vice President and Chief Regulatory Counsel of Medtronic, as…
8-K — Impact 3/10
Sep 3, 2026 Insider
Smith Trent N. was granted 15,000 shares
CFO
Sep 3, 2026 Insider
Hauser Bradley was granted 27,000 shares
CEO and President
Sep 3, 2026 Insider
Bisson Lori was granted 13,000 shares
Director
Dec 31, 2025 Inst.
Mariner, LLC — TRIM
53,143 shares ($26.5K)

SecBot reports

13 filings · 1 bullish · 4 bearish · 1 mixed · 7 neutral
All AMIX filing & press-release reports (13)